Alpha 2.0
Login Register
» Articles » PMID: 27538663

The Use of Medical-grade Cannabis in Patients Non-responders to Nabiximols

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2016 Aug 20
PMID 27538663
Citations 5
Authors
Francesco Sacca
Chiara Pane
Antonio Carotenuto
Marco Massarelli
Roberta Lanzillo
Ettore Brunello Florio
Vincenzo Brescia Morra
Affiliations
Soon will be listed here.
Citing Articles

The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review.

Leen N, Kowal M, Batalla A, Bossong M Front Pharmacol. 2024; 15:1411631.

PMID: 39484170 PMC: 11524849. DOI: 10.3389/fphar.2024.1411631.

Concerns Related to the Consequences of Pediatric Cannabis Use: A 360-Degree View.

Padoan F, Colombrino C, Sciorio F, Piacentini G, Gaudino R, Pietrobelli A Children (Basel). 2023; 10(11).

PMID: 38002812 PMC: 10670833. DOI: 10.3390/children10111721.

Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis.

Belgers V, Rottgering J, Douw L, Klein M, Ket J, van de Ven P Cannabis Cannabinoid Res. 2022; 8(1):41-55.

PMID: 35861789 PMC: 9940814. DOI: 10.1089/can.2021.0187.

The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series.

Pane C, Sacca F Neurol Sci. 2019; 41(3):695-698.

PMID: 31776867 DOI: 10.1007/s10072-019-04162-1.

Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.

Olah A, Szekanecz Z, Biro T Front Immunol. 2017; 8:1487.

PMID: 29176975 PMC: 5686045. DOI: 10.3389/fimmu.2017.01487.